Ernexa Therapeutics (ERNAW) EBT Margin (2010 - 2024)
Ernexa Therapeutics (ERNAW) reported EBT Margin of 204110.53% for Q4 2024, up 21664114.0% on a YoY basis from N/an in Q1 2024, and up 3838.03% quarter-over-quarter from 5460.37% in Q3 2024.
Ernexa Therapeutics (ERNAW) EBT Margin (2010 - 2024) Analysis & Trends
Ernexa Therapeutics has reported EBT Margin for 13 years, with the latest figure at 204110.53% in Q4 2024.
- For the quarter ending Q4 2024, EBT Margin rose 21664114.0% year-over-year to 204110.53%; the trailing twelve-month figure through Dec 2024 stood at 3.33% (up 2165733.0% YoY), and the FY2024 full-year result was 3.33%, up 2165733.0% from the prior year.
- EBT Margin for Q4 2024 stood at 204110.53%, up from 5460.37% in the prior quarter.
- The five-year high for EBT Margin was 204110.53% in Q4 2024, with the low at 14134.04% in Q1 2024.
- Historically, EBT Margin has averaged 16542.19% across 3 years, with a median of 5460.37% in 2024.
- Annual changes were most pronounced in 2020 — EBT Margin tumbled 19160 bps — and 2024, when it soared 21664114 bps.
- Ernexa Therapeutics' EBT Margin stood at 216.68% in 2020, then sank by 5683 bps to 12530.61% in 2023, then surged by 1729 bps to 204110.53% in 2024.
- The last three EBT Margin figures came in at 204110.53% (Q4 2024), 5460.37% (Q3 2024), and 11757.45% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 204,110.53% |
| Sep 30, 2024 | -5,460.37% |
| Jun 30, 2024 | -11,757.45% |
| Mar 31, 2024 | -14,134.04% |
| Dec 31, 2023 | -12,530.61% |
| Sep 30, 2023 | -10,978.43% |
| Dec 31, 2020 | -216.68% |
| Sep 30, 2020 | -101.56% |
| Mar 31, 2020 | -51.67% |
| Dec 31, 2019 | -25.08% |
| Sep 30, 2019 | -7.25% |
| Jun 30, 2019 | -1.72% |
| Mar 31, 2019 | -6.25% |
| Dec 31, 2018 | -0.81% |
| Sep 30, 2018 | 3.86% |
| Jun 30, 2018 | -1.77% |
| Mar 31, 2018 | -7.06% |
| Dec 31, 2017 | -6.96% |
| Sep 30, 2017 | -3.37% |
| Jun 30, 2017 | -2.85% |